grain-elipse1
grain-elipse

New rapid test to detect heart and cancerogenic pathologies

Published August 10, 2022
Categories: Health Science
Rapid Test

Scientists developed innovative test use in implementation and being able to quickly detect non-communicable ailments, such as carcinomas or heart diseases. This test identifies biological markers’ signals; it’s already evolved in COVID-19 virus detection, when SARS-CoV-2 presence means a positive result.

The test is susceptible to biological markers of non-communicable ailments; f. eg., prostate specific antigen in blood might be considered a biological marker signaling cancer cells  development in prostate gland. Certainly, a patient with these clinical suspicions is prescribed a comprehensive examination, the grounds for which may be the results of the test.

Clinical Benefits of Innovative Method

RNA or DNA diagnosis often requires a clear temperature regime and involves the use of many technical components. This test might be realistically performed at area temperature in normal home conditions. Scientists are confident that this can guarantee faster and easier diagnosis in the general practice clinic, as well as in hospitals with minimal capacity in countries with a low level of development.

An innovative test called Crispr Zyme could improve “admission” to the identification of biological markers. In addition, this tequinic is able to take humanity a few steps closer to home tests without intervention of a medical specialist. Soon, the diagnosis will become much easier, which will also reduce the number of additional diagnoses.

New test is based on CRISPR methods implementing RNA to detect urine or blood markers. In their version, such tests identify RNA, and amplify them, forming a mass of copies, for the convenience of obtaining a biological signal.

However, what is a certain disadvantage of this method, although it can be used to identify cancer cells, it does not give data on how many biological markers are present, but it’s significant for tracking the development of the disease.

Scientists are trying in every possible way to improve this technique, changing amplification to colorimetric analysis – a technique identifying the number of biological markers. Thanks to it, there is no need to monitor temperatures and do something extra, and it is also possible to determine the number of biological markers in the sample.

In general, Crispr Zyme is a more simplified diagnostic method than existing ones. It also differs in that it can show how many biological markers are present in the body, which helps not only to identify the disease, but also to track its progression.

After all the research, scientists hope that this test will give a chance to get closer to personalized therapeutic practice, with help of which cure will fully meet patients’ needs. For amplification stage elimination, scientists implemented nanozymes, microscopic synthetics that work like enzymes. These activities improve test signals; it makes colorimetric analysis easier to perform.

This tequinic doesn’t 100% expel all testing stages, because samples should also be processed with chemical compounds to obtain the required biological marker before testing. Scientists continue to improve their own technology, exploring alternative ways to process samples to maximize the convenience of users.

Related insights

December 8, 2022
Categories: Health

Nanoparticles Upgraded to Deliver Killer Sting on Recalcitrant Tumors

Adaptor proteins called STING (stimulator of interferon genes) aid the immune system in identifying pathogens and cancerous cells. Drugs that...
December 8, 2022
Categories: Health

How to Prevent Hearing Loss Caused by Antibiotics

Hearing loss caused by antibiotics can be prevented by biological pathways as suggested by scientists at IU School of Medicine....
December 8, 2022
Categories: Health

One drug to fight both muscle and bone deterioration

In a recent research made public in an open-access, peer-reviewed journal Bone Research, scientists from Japan set up a new drug test system...
December 8, 2022
Categories: Health

New liquid biopsy detects signs of breast cancer in early-stage patients

The scientists from USC Michelson Center CSI-Cancer have determined that a laboratory analysis of blood under the name of a liquid...
December 1, 2022
Categories: Science

Researchers created a new surgical training model for cancer surgery

Konnyaku, a prepared jelly formed from the konjac plant’s bulb, has been efficiently used by scientists from Nagοya University to...
Prev
Next

Have any questions?

Send us a request and we will contact you as soon as possible.

loader

We are in social networks

  • The goal that we have set for ourselves is the acquisition by the human body of the ability to remain young and healthy as long as possible – practically, the acquisition of immortality by a person.

    A young man at 100 years of age? Why not? And this is just the tip of the iceberg of our plans.

  • The main and most global goal of the project is to gain immortality. However, to achieve this goal, there is a lot of work to be done: from introducing the latest developments in medical practice, which already now can significantly improve health and prolong life, to conducting scientific research that will help achieve our global goal.

  • A fund or a company interested in investing in our project can contact us via the contact form to clarify all the details. The main condition is the sharing of project values ​​and the desire to change the world for the better together with us.

    In addition, we plan to issue our own NFT collection, by purchasing which you will also be able to invest in the project.

  • Since we create the ELC project from scratch and fully cover all our activities in social networks, you can learn about all promotions and developments from our official pages and website. One of the first public results will be the presentation of the project at the Eternity Life Forum, where we will present our project, with its ideas and developments.